Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Government monitoring glanders outbreaks in Turkey
Keepers of all Equidae are being reminded to maintain high standards of biosecurity and report any susect clinical signs promptly.

Equine owners urged to maintain high standards of biosecurity

Government officials are monitoring an outbreak of glanders in Turkey after the World Health Organisation (OIE) reported three cases of the disease in the country.

Glanders is an often-fatal condition caused by the bacteria Burkholderia malle, primarily affecting horses, donkeys and mules. The disease is spread through close contact with infected animals, or via food and water contaminated with discharges from the respiratory tract or ulcerated skin lesions of contaminated animals. 


On Friday (10 January), Defra/the APHA's International Disease Monitoring Team published a preliminary outbreak assessment of the situation after glanders was reported in Turkey for the first time since 2017. 


The first three of the outbreaks were confirmed on the 23 December 2019 during a routine screening. Two of these outbreaks were identified in the Mudurnu district in North-West Turkey, where 10 out of 85 susceptible horses tested positive for the disease and were subsequently culled.


Officials identified the third case in the Adalar Region of Istanbul, where certain permissions and conditions must be met to move horses in line with the 2018/1301 EC Directive. The animals are reported to have been brought into the district illegally, without microchips, identification documents or veterinary health certificates. 


‘All horses within the district were subsequently subject to serological and mallein tests for Glanders,' the Assessment notes. 'Quarantine, cleansing and disinfection measures have been applied, and equine movement in and out of the districts have been prohibited. All horses in the district will be subject to a follow-up test 20 days after initial testing.’


A fourth outbreak was reported on 30 December 2019 in a single horse in the Merkez district, some 260km south-west of the initial outbreaks. A private veterinary surgeon suspected glanders via the clinical signs and a mallei test identified the disease. This region is not approved for export of Equidae to the EU.

The International Disease Team said that it is continuing to monitor the situation and is reminding keepers of all Equidae ‘to maintain high standards of biosecurity and report any suspect clinical signs promptly.’

For more information about glanders and its clinical signs, vist at www.oie.int

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.